Home
World Journal of Advanced Research and Reviews
International Journal with High Impact Factor for fast publication of Research and Review articles

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Reviewer Panel
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

eISSN: 2581-9615 || CODEN: WJARAI || Impact Factor 8.2 ||  CrossRef DOI

Research and review articles are invited for publication in March 2026 (Volume 29, Issue 3) Submit manuscript

Mirtazapine in Primary Insomnia: Case report and Literature review

Breadcrumb

  • Home
  • Mirtazapine in Primary Insomnia: Case report and Literature review

Asad Riaz 1, *, Qandeel Shahid 2, Hafiz Mansoor Yousaf 3, Usama Gul 4, Syed Saifullah Shah 5, Aabdar Hidayat 6, Tauseef Hamid 7, Anees Ur Rahman 8, Muhammad Usman 9, Muhammad Kinwan Khan 10, Rafia Muhtiar 11 and Behram Khalid 12

1 Department of General Surgery, Ayub Teaching Hospital, Abbottabad, Pakistan.
2 Department of Psychiatry, Haytabad Medical Complex, Peshawar, Pakistan.
3 Department of Otorhinolaryngology/ENT, Haytabad Medical Complex, Peshawar, Pakistan.
4 Department of Psychiatry, Haytabad Medical Complex, Peshawar, Pakistan.
5 Department of General Medicine, Lady Reading Hospital, Peshawar, Pakistan.
6 Department of General Medicine, Khyber Teaching Hospital, Peshawar, Pakistan.
7 Department of General Medicine, Saidu Group of Teaching Hospitals, Swat, Pakistan.
8 Department of General Medicine, Mardan Medical Complex, Mardan, Pakistan.
9 Department of Paediatrics, Medicsi Hospital, Islamabad, Pakistan.
10 Department of Community Medicine, Northwest School of Medicine, Peshawar, Pakistan.
11 Department of Anatomy, Gajju Khan Medical College, Swabi, Pakistan.
12 Department of General Medicine, Saidu Group of Teaching Hospitals, Swat, Pakistan.
 
Case Study
World Journal of Advanced Research and Reviews, 2024, 23(01), 2576-2581
Article DOI: 10.30574/wjarr.2024.23.1.2213
DOI url: https://doi.org/10.30574/wjarr.2024.23.1.2213
 
Received on 13 June 2024; revised on 24 July 2024; accepted on 26 July 2024
 
Introduction: Insomnia is a prevalent sleep disorder characterized by difficulty in falling asleep, maintaining sleep, or achieving restorative sleep, despite adequate opportunities. This condition often results in significant daytime impairments, including fatigue, concentration difficulties, and irritability. Insomnia can be primary or comorbid with other disorders such as anxiety or depression. 
Case Presentation: A 27-year-old woman presented with severe and chronic insomnia, persisting for 14 years with recent exacerbation. Her symptoms included significant difficulty in initiating and maintaining sleep, resulting in an average of only 3-4 hours of sleep per night and complete sleep deprivation for periods exceeding half an hour over the past 5 days. This sleep deficit led to pronounced emotional instability, physical discomfort, and reduced appetite, although suicidal ideation was absent. She had a past history of drug use for different psychiatric illnesses. She was started on mirtazipine 30mg and showed abrupt improvement in her symptoms. She was discharged afterwards.
Discussion:  The patient's chronic insomnia and its secondary effects necessitate a comprehensive treatment approach. Mirtazapine, an antidepressant with potent histamine receptor antagonism, has shown efficacy in improving sleep quality across diverse patient profiles. However, side effects like weight gain and sedation require careful monitoring. Combining mirtazapine with prolonged-release melatonin has demonstrated enhanced outcomes, particularly in perimenopausal women. Cognitive Behavioral Therapy for Insomnia (CBT-I) remains the first-line treatment due to its efficacy and long-term benefits.
Conclusion: Mirtazapine can be a valuable option in the therapeutic arsenal for primary insomnia, but ongoing research is needed to refine treatment strategies. Personalized treatment plans considering patient history and response are crucial for effectively managing primary insomnia and improving patient outcomes.
 
Insomnia; Sleep disorder; Mirtazapine; Sleep quality; Cognitive Behavioral Therapy for Insomnia (CBT-I); Prolonged-release melatonin; Emotional instability; Antidepressant; Histamine receptor antagonism.
 
https://wjarr.com/sites/default/files/fulltext_pdf/WJARR-2024-2213.pdf

Preview Article PDF

Asad Riaz, Qandeel Shahid, Hafiz Mansoor Yousaf, Usama Gul, Syed Saifullah Shah, Aabdar Hidayat, Tauseef Hamid, Anees Ur Rahman, Muhammad Usman, Muhammad Kinwan Khan, Rafia Muhtiar and Behram Khalid. Mirtazapine in Primary Insomnia: Case report and Literature review. World Journal of Advanced Research and Reviews, 2024, 23(1), 2576-2581. Article DOI: https://doi.org/10.30574/wjarr.2024.23.1.2213

Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


All statements, opinions, and data contained in this publication are solely those of the individual author(s) and contributor(s). The journal, editors, reviewers, and publisher disclaim any responsibility or liability for the content, including accuracy, completeness, or any consequences arising from its use.

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content

Copyright © 2026 World Journal of Advanced Research and Reviews - All rights reserved

Developed & Designed by VS Infosolution